{"paper_id":"346191ad-2fad-4528-b6f7-c26414ad534c","body_text":"Abstract\nObjective:To evaluate the effect of prolonged Gonadotropin releasing hormone (GnRH) agonist downregulation in patients with endometriomas of less than 5 cm on the outcome of the proceeding Intracytoplasmic sperm injection (ICSI) trial. Methods: In a randomized controlled trial at a university teaching hospital, 90 patients indicated for ICSI and having unilateral single endometrioma of less than 5 cm in diameter were randomized into 2 groups. Group A (45 patients) received the standard long protocol; whereas group B (45 patients) received 3 consecutive Intramuscular (IM) injections of triptorelin 3.75 mg 28 days apart followed by the standard long protocol 28 days after the last injection. Results: There were no significant differences in the clinical and hormonal characteristics between the 2 groups. All ICSI cycle characteristics including number of retrieved oocytes, fertilized oocytes, and transferred embryos were also not significantly different. However, patients who received prolonged GnRH agonist therapy showed significantly higher chemical (P = .011), clinical (P = .018), and ongoing (P = .028) pregnancy rates. Conclusion: Prolonged GnRH agonist downregulation improves the pregnancy rates in patients with small endometriomas undergoing ICSI.\nSimilar content being viewed by others\nReferences\nOzkan S, Murk W, Arici A. Endometriosis and infertility: epidemiology and evidence-based treatments. Ann N Y Acad Sci. 2008; 1127:92–100.\nRedwine DB. Ovarian endometriosis: a marker for more extensive pelvic and intestinal disease. Fertil Steril. 1999;72(2):310–315.\nDonnez J, Nisolle M, Gillet N, Smets M, Bassil S, Casanas-Roux F. Large ovarian endometriomas. Hum Reprod. 1996; 11(3):641–646.\nYoung VJ, Brown JK, Saunders PT, Horne AW. The role of the peritoneum in the pathogenesis of endometriosis. Hum Reprod Update. 2013;19(5):558–569.\nPellicer A, Albert C, Mercader A, Bonilla-Musoles F, Remohi J, Simon C. The follicular and endocrine environment in women with endometriosis: local and systemic cytokine production. Fertil Steril. 1998;70(3):425–431.\nWu HN, Wu MY, Yang YS. Peritoneal cellular immunity and endometriosis. Am J Reprod Immunol. 1997;38(6):400–412.\nCarlberg M, Nejaty J, Froysa B, Guan Y, Soder O, Bergqvist A. Elevated expression of tumor necrosis factor alpha in cultured granulosa cells from women with endometriosis. Human Reprod. 2000;15(6):1250–1255.\nToya M, Saito H, Ohta N, Saito T, Kaneko T, Hiroi M. Moderate and sever endometriosis is associated with alterations in the cell cycle of granulosa cells in patients undergoing in vitro fertilization and embryo transfer. Fertil Steril. 2000;73(2):344–350.\nSenturk LM, Arici A. Immunology of endometriosis. J Reprod Immunol. 1999;43(1);67–83.\nPellicer A, Valbuena D, Bauset C, et al. The follicular endocrine environment in stimulated cycles of women with endometriosis: steroid levels and embryo quality. Fertil Steril. 1998; 69(6):1135–1141.\nSmith MP, Keay SD, Margo FC, et al. Total cortisol levels are reduced in the preovulatory follicle of infertile women with minimalmild endometriosis. Am J Reprod Immunol. 2002; 47(1):52–56.\nSanchez AM, Vigano P, Somigliana E, Panina-Bordignon P, Vercellini P, Candiani M. The distinguishing cellular and molecular features of the endometriotic ovarian cyst: from pathophysiology to the potential endometrioma-mediated damage to the ovary. Hum Reprod Update. 2014;20(2):217–230.\nHamdan M, Dunselman G, Li TC, Cheong Y. The impact of endometrioma on IVF/ICSI outcomes: a systematic review and meta-analysis. Hum Reprod Update. 2015;21(6):809–825.\nGupta S, Agarwal A, Agarwal R, Loret de Mola JR. Impact of ovarian endometrioma on assisted reproduction outcomes. Reprod Biomed Online. 2006;13(3):349–360.\nArici A, Oral E, Bukulmez O, Duleba A, Olive DL, Jones EE. The effect of endometriosis on implantation: results from the Yale University in vitro fertilization and embryo transfer program. Fertil Steril. 1996;65(3):603–607.\nHuang A, Hunter M, DeCherney AH. Endometriosis and ART. In: Gardner DK, Weissman A, Howles CM, Shoham Z, eds. Textbook of Assisted Reproductive Technologies. 3rd ed. United Kingdom: Informa; 2009.\nSurrey ES. Endometriosis-related infertility: the role of the assisted reproductive technologies. Biomed Res Int. 2015;2015: 482959.\nDunselman GA1, Vermeulen N, Becker C. European Society of Human Reproduction and Embryology. ESHRE guideline: management of women with endometriosis. Hum Reprod. 2014 Mar; 29(3):400–412. doi: 10.1093/humrep/det457. Epub 2014 Jan 15.\nBarnhart K, Dunsmoor-Su R, Coutifaris C. Effect of endometriosis on in vitro fertilization. Fertil Steril. 2002; 77(6):1148–1155.\nKuivasaari P, Hippelainnen M, Anttila M, Heinonen S. Effect of endometriosis on IVF/ICSI outcome: stage III/IV endometriosis worsens cumulative pregnancy and live-born rates. Hum Reprod. 2005;20(11):3130–3135.\nDlugi AM, Loy RA, Dieterle S, Bayer SR, Seibel MM. The effect of endometriosis on in vitro fertilization outcome. J In Vitro Fert Embryo Transf. 1989;6(6):338–341.\nSomigliana E, Infantino M, Benedetti F, et al. The presence of ovarian endometriomas is associated with reduced responsiveness to gonadotropins. Fertil Steril. 2006;86(1):192–196.\nYanushpolsky EH, Best CL, Jackson KV, et al. Effects of endo-metriomas on oocyte quality, embryo quality, and pregnancy rates in in vitro fertilization cycles: a prospective, case-controlled study. J Assist Reprod Genet. 1998;15(4):193–197.\nVan Holsbeke C, van Calster B, Guerriero S, et al. Endometriomas: their ultrasound characteristics. Ultrasound Obstet Gynecol. 2010;35(6):730–740.\nVladareanu R, Andrei Ch, Zvanca M. Newer developments in ultrasound in infertility. In: Kurjak A, Chervenak FA, eds. Donald School Textbook of Ultrasound in Obstetrics and Gynecology. 3rd ed. India: Jaypee Brothers Medical Publishers(P) Ltd; 2011.\nPapanikolaou E, D’haeseleer E, Verheyen G, et al. Live birth rate is significantly higher after blastocyst transfer when at least four embryos are available on day 3 of embryo culture. A randomized prospective study. Hum Reprod. 2005;20(11):3198–3203.\nSallam HN, Garcia-Velasco JA, Dias S, Arici A. Long-term pituitary down-regulation before in vitro fertilization (IVF) for women with endometriosis. Cochrane Database Syst Rev. 2006;(1): CD004635.\nKim CH, Cho YK, Mok JE. Simplified ultralong protocol of gonadotropin releasing hormone agonist for ovulation induction with intrauterine insemination in patients with endometriosis. Hum Reprod. 1996;11(2):398–402.\nDicker D, Goldman JA, Levy T, Feldberg D, Ashkenazi J. The impact of long-term gonadotropin releasing hormone analogue treatment on preclinical abortions in patients with severe endo-metriosis undergoing in vitro fertilization-embryo transfer. Fertil Steril. 1992;57(3):597–600.\nRickes D, Nickel I, Kropf S, Kleinstein J. Increased pregnancy rates after ultralong postoperative therapy with gonadotropin releasing hormone analogues in patients with endometriosis. Fertil Steril. 2002;78(4):757–762.\nSurrey ES, Silverberg KM, Surrey MW, Schoolcraft WB. Effects of prolonged gonadotropin releasing hormone agonist therapy on the outcome of in vitro fertilization-embryo transfer in patients with endometriosis. Fertil Steril. 2002;78(4):699–704.\nNakamura K, Oosawa M, Kondou I, et al. Metrodin stimulation after prolonged gonadotropin releasing hormone agonist pretreat-ment for in vitro fertilization in patients with endometriosis. J Assist Reprod Genet. 1992;9(2):113–117.\nChedid S, Camus M, Smitz J, et al. Comparison among different ovarian stimulation regimens for assisted reproduction procedures in patients with endometriosis. Hum Reprod. 1995; 10(9):2406–2411.\nConn PM, Huckle WR, Andrews WV, et al. The molecular mechanism of action of gonadotropin releasing hormone (GnRH) in the pituitary. Recent Prog Horm Res. 1987;43:29–68.\nMeresman GF, Bilotas MA, Lombardi E, et al. Effect of GnRH analogues on apoptosis and release of interleukin-1b and vascular endothelial growth factor in endometrial cell cultures from patients with endometriosis. Hum Reprod. 2005;18(9):1767–1771.\nLebovic DI, Bentzien F, Chao VA, et al. Introduction of an angiogenic phenotype in endometriotic stromal cell cultures by interleukin-1β. Mol Hum Reprod. 2000;6(3):269–275.\nMc Laren J. Vascular endothelial growth factor (VEGF) and endo-metriotic angiogenesis. Hum Reprod Update. 2000;6(1):45–55.\nDe la Fuente G, Garcia-Velasco JA. Ovarian endometriosis: effect on IVF outcome. In: Gardner DK, Rizk B, Falcone, eds. Human Assisted Reproductive Technology. New York: Cambridge University Press; 2011.\nNezhat F, Nezhat C, Allan CJ, Metzger DA, Sears DL. Clinical and histologic classification of endometriomas. Implications for a mechanism of pathogenesis. J Reprod Med. 1992;37(9):771–776.\nAuthor information\nAuthors and Affiliations\nCorresponding author\nRights and permissions\nAbout this article\nCite this article\nMaged, A.M., Rashwan, H., Mahmoud, M. et al. Effect of Prolonged GnRH Agonist Downregulation on ICSI Outcome in Patients With Endometriomas of Less Than 5 cm: A Randomized Controlled Trial. Reprod. Sci. 25, 1509–1514 (2018). https://doi.org/10.1177/1933719118756753\nPublished:\nVersion of record:\nIssue date:\nDOI: https://doi.org/10.1177/1933719118756753","source_license":"CC0","license_restricted":false}